Stay updated with breaking news from Results Will. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Takeda TSE4502NYSETAK today announced positive topline results from a randomized doubleblind placebocontrolled multiple dose Phase 2b trial evaluating TAK861 an oral orexin receptor 2 OX2R agonist in patients with narcolepsy type 1.
− Primary and Key Secondary Endpoints Were Met in Narcolepsy Type 1 Phase 2b Trial− TAK-861 Was Found to be Generally Safe and Well-Tolerated− Results Will be Presented at an Upcoming Scientific CongressOSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda (TSE:4502/NYSE:TAK) today announced positive topline resu...
Town have suffered few disappointments this season and skipper Sam Morsy believes that as long as performance levels are consistent there is every reason to believe that the team’s current status can be maintained through to the end of the season.
Unfälle, Naturkatastrophen, Brände und Kriminalität. n-tv informiert über das Geschehen in aller Welt.
Unfälle, Naturkatastrophen, Brände und Kriminalität. n-tv informiert über das Geschehen in aller Welt.